The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of a randomized weight loss trial on breast tissue markers in breast cancer survivors.
 
Christina Marie Dieli-Conwright
No Relationships to Disclose
 
Maura Harrigan
No Relationships to Disclose
 
Brenda Cartmel
No Relationships to Disclose
 
Anees B. Chagpar
Leadership - Protean Biodiagnostics
Consulting or Advisory Role - Athenex; Genomic Health; Lumicell; Puma Biotechnology
 
Yalai Bai
No Relationships to Disclose
 
David L. Rimm
Stock and Other Ownership Interests - Pixel Gear
Honoraria - Amgen; Bristol-Myers Squibb; Ventana Medical Systems
Consulting or Advisory Role - Agendia; AstraZeneca; Bristol-Myers Squibb; Cell Signaling Technology; Cepheid; Daiichi Sankyo; GlaxoSmithKline; Konica Minolta; Merck; NanoString Technologies; NextCure; PAIGE.AI; Perkin Elmer; Roche; Sanofi; Ultivue
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Cepheid (Inst); Konica Minolta (Inst); Lilly (Inst); NanoString Technologies (Inst); Navigate Biopharma (Inst); NextCure (Inst); Perkin Elmer (Inst); Ultivue (Inst)
Patents, Royalties, Other Intellectual Property - Quantitative Immunofluorescence (AQUA) (Inst); Rarecyte Circulating tumor cells
Travel, Accommodations, Expenses - Bristol-Myers Squibb; NextCure; Ventana Medical Systems
 
Lajos Pusztai
Consulting or Advisory Role - Almac Diagnostics; AstraZeneca; Athenex; Bristol Myers Squibb; Clovis Oncology; Eisai; H3 Biomedicine; Immunomedics; Merck; Novartis; Roche/Genentech; Seagen; Syndax
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca
(OPTIONAL) Uncompensated Relationships - Foundation Medicine; NanoString Technologies
 
Lingeng Lu
No Relationships to Disclose
 
Tara B. Sanft
No Relationships to Disclose
 
Melinda L. Irwin
No Relationships to Disclose